SCM
ABEO icon

Sterling Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Sterling Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.44K Buy
880
+534
+154% +$2.93K ﹤0.01% 2564
2026
Q1 		$1.55K Sell
346
-81
-19% -$405 ﹤0.01% 3036
2025
Q4 		$2.25K Buy
427
+169
+66% +$851 ﹤0.01% 3051
2025
Q3 		$1.36K Buy
258
+96
+59% +$609 ﹤0.01% 3037
2025
Q2 		$920 Buy
+162
New +$922 ﹤0.01% 3075

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sterling Capital Management's ABEO Position: Q2 2026 in Review

Sterling Capital Management increased its Abeona Therapeutics (ABEO) stake by 154% in Q2 2026, buying an estimated $2.93K and bringing the position to 880 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Sterling Capital Management first reported a position in ABEO in Q2 2025 and has held it in 5 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Sterling Capital Management held 880 shares of Abeona Therapeutics worth $5.44K as of Q2 2026.
  • Sterling Capital Management bought 534 Abeona Therapeutics shares in Q2 2026, an estimated $2.93K.
  • Abeona Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2564 holding.
  • Sterling Capital Management first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.